{
    "nct_id": "NCT06056830",
    "official_title": "Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants with High-risk Prostate Cancer Prior to Radical Prostatectomy: a Prospective, Single-arm, Multi-center, Blinded-review, Phase 3 Diagnostic Performance Study",
    "inclusion_criteria": "* At least 18 years of age.\n* Signed informed consent.\n* Untreated, histologically confirmed adenocarcinoma of the prostate.\n* High-risk or greater PC defined by National Comprehensive Cancer Network Guidelines Version 1.202327 (clinical stage ≥T3a, or Grade Group ≥4, or PSA >20 ng/mL).\n* Patients electing to undergo RP with PLND.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Administration of any high energy (>300 KeV) gamma-emitting radioisotope within 5 physical half-lives prior to Day 1.\n* Known or expected hypersensitivity to 64Cu-SAR-bisPSMA or any of its components.\n* Patients with known predominant small cell or neuroendocrine PC.",
    "miscellaneous_criteria": ""
}